XXXX in Thailand: a hospital-based survey.

@entity1 @entity410 @entity739 @entity1245 @entity2473 @entity302 @entity109
The prevalence of @entity739 in Thailand had not been studied. During January 1997 to December 1999, at the Department of Pediatrics, Ramathibodi Hospital, Bangkok, Thailand, of the total 628 first seen @entity302 @entity1 , aged 0-15 years, 31 @entity1 (4.9%) with @entity739 were encountered. Sixteen were males. The mean age at presentation was 9.7 months (range 4-32 months) and at @entity410 onset was 5.7 months (range 2-11 months). Twenty-two @entity1 had typical @entity2473 , four each had generalized tonic @entity410 and focal @entity410 prior to the onset of @entity739 , and another @entity1 had @entity410 . Nineteen @entity1 were classified as symptomatic. Electroencephalogram revealed @entity739 in six @entity1 , multifocal independent @entity302 in 24 @entity1 , and focal @entity302 in four @entity1 . Abnormal brain-imaging findings were demonstrated in six of the 11 @entity1 investigated. Vigabatrin was given to 17 @entity1 whereas one @entity1 was given valproate. Others who had been severely retarded were given @entity109 in combination with @entity1245 . Six @entity1 were lost to follow-up. Of the remaining @entity1 , the duration of follow-up ranged from 7 to 44 months (mean 28 months). Infantile @entity2473 disappeared in 11 @entity1 , persisted in six @entity1 , and changed to other form in eight @entity1 . The developmental outcome was apparently normal in five, slightly delayed in four, moderately delayed in ten, and severely delayed in eight @entity1 .
